Assignee
KLING BIOTHERAPEUTICS B V
NL·4 granted patents·5 pending applications·0 citations·filing 2016–2024
Top patents by PatentIndex Score
9 records- 0178US2024425566A1Ex vivo antibody productionKLING BIOTHERAPEUTICS B V·Filed 2024·Application pending·0 cites
- 0273US2023242667A1Means and methods for counteracting myeloproliferative or lymphoproliferative disordersKLING BIOTHERAPEUTICS B V·Filed 2023·Application pending·0 cites
- 0372US2024360239A1Therapeutic Anti-CD9 AntibodyKLING BIOTHERAPEUTICS B V·Filed 2024·Application pending·0 cites
- 0467US12084681B2Ex vivo antibody productionKLING BIOTHERAPEUTICS B V·Filed 2019·Granted Sep 10, 2024·0 cites·19 claims
- 0565US11999793B2Therapeutic anti-CD9 antibodyKLING BIOTHERAPEUTICS B V·Filed 2021·Granted Jun 4, 2024·0 cites·16 claims
- 0665US2023235018A1Aml antigens and uses thereofKLING BIOTHERAPEUTICS B V·Filed 2022·Application pending·0 cites
- 0764US11629200B2Means and methods for counteracting myeloproliferative or lymphoproliferative disordersKLING BIOTHERAPEUTICS B V·Filed 2020·Granted Apr 18, 2023·0 cites·16 claims
- 0852US11524989B2AML antigens and uses thereofKLING BIOTHERAPEUTICS B V·Filed 2016·Granted Dec 13, 2022·0 cites·9 claims
- 0950US2024317880A1Epithelial Cadherin-Specific AntibodiesKLING BIOTHERAPEUTICS B V·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KLING BIOTHERAPEUTICS B V files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →